SEER Inquiry System - Home
Welcome to the SEER Inquiry System (SINQ). SINQ is a collection of questions that cancer registrars have had while coding cancer cases. Click Search to look for specific questions or to select questions for a Report.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Add to Report | ID | Question | Status | Last Updated | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091092 | MP/H Rules-Lung: What is the Diagnosis Date, Diagnostic Confirmation and histology for the left lung mass? Scenario: PET shows a 3 cm mass in the left lung and a 2.9 cm mass in the right lung. No reportable terminology in PET. The right mass is biopsied and shows adenoca. The left mass is not biopsied. Based on rule M6, this should be reported as two primaries. No additional information in medical record, pt expired. |
Final | Aug 27 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091090 | First course treatment--Leukemia: Should an allogeneic stem cell transplant for acute myeloid leukemia be coded to 20 in the Hematologic Transplant and Endocrine Procedures? There is debate as to whether this procedure should be coded as a 12 in order to capture the allogeneic part of the procedure. | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091089 | Histology--Hematopoietic: The final diagnosis on a bone marrow biopsy was "chronic lymphocytic leukemia with plasmacytic differentiation." Is this coded 9823/3, CLL/SLL or 9733/3, plasma cell leukemia? | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091088 | MP/H Rules/Histology--Breast: How is histology coded? Right breast simple mastectomy, path: 2.5 x 1.5 x 1.5 cm metaplastic carcinoma with; the sarcomatous component is high grade sarcoma with focal areas of osteoid formation. The epithelial component is predominantly grade 2 DCIS. | Final | Oct 29 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091087 | Reportability--Appendix: Does the statement of "metastatic" make this reportable? Low-grade appendiceal mucinous neoplasm; Lt ovary, cul-de-sac, omentum, and small bowel: Metastatic low-grade appendiceal mucinous neoplasm. Per pathologist this is a borderline tumor of the appendix. | Final | Oct 02 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091085 | MP/H Rules/Histology--Breast: What is the correct histology code for this breast cancer case? Final diagnosis says, "Infiltrating duct carcinoma with apocrine features." What rule is used? See also discussion. | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091084 | Primary site--Colon: How do you determine the correct subsite when there is conflicting information in different reports? See discussion for case example. In this case, the Operative report seems more correct. Are there priority rules for this for sites other than Head and Neck? | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091083 | Grade/Cell indicator--Lymphoma: For pathology that states "anaplastic large cell lymphoma", is the grade code 4? The SPCM states cell indicator codes take precedence over grade/differentiation codes for lymphoma and leukemia cases. | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091082 | Behavior--Breast: What is the correct behavior code for these 2 scenarios? 1. Path report for breast cancer has final diagnosis as 'DCIS' but the CAP protocol in the body of the report says 'microinvasion seen, T1mic.' 2. Path report says 'DCIS' in the final diagnosis and microinvasion is identified in the microscopic portion of the report, but it is not in CAP protocol format and not stated in the final diagnosis. These are path reports from lab only cases (not otherwise reported to the central registry). |
Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20091081 | Reportability/Histology--Brain and CNS: Histology code 8825/1 (Inflammatory Myofibroblastic Tumor) is not listed in the ICD-0-3 Primary Brain and CNS Site/Histology listing for reportable Brain/CNS tumors. It seems this might be a reportable tumor? | Final | Aug 10 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
